Eris Lifesciences Limited

NSE:ERIS.NS

1306.25 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 7,389.57,197.25,509.254,834.815,005.24,600.293,965.924,178.44,553.323,920.523,011.013,280.743,533.373,436.562,742.533,050.423,252.672,880.122,440.852,617.532,804.562,718.892,110.852,484.782,605.622,507.612,121.922,089.712,492.341,852.071,591.481,844.71,989.161,824.23
Cost of Revenue 1,862.73,891.52,745.59888.69945.97783.95727.57887.821,057.2850.91640.9614.4664688.66640.27564.29638.29575.85443.04428.18457.21458.93363.21393.92405.65388.66351.19336.69399.76274.58304.47221.04233.26309.26
Gross Profit 5,526.83,305.72,763.663,946.124,059.233,816.343,238.353,290.583,496.123,069.612,370.112,666.342,869.372,747.92,102.262,486.132,614.382,304.271,997.812,189.352,347.352,259.961,747.642,090.862,199.972,118.951,770.731,753.022,092.581,577.491,287.011,623.661,755.91,514.97
Gross Profit Ratio 0.7480.4590.5020.8160.8110.830.8170.7880.7680.7830.7870.8130.8120.80.7670.8150.8040.80.8180.8360.8370.8310.8280.8410.8440.8450.8340.8390.840.8520.8090.880.8830.83
Reseach & Development Expenses 00000061000327.3800050.9200041.9600041.120007.740000000
General & Administrative Expenses 0000001,189.54000633.63000582.44000633.57000651.67000496.67000380.77000
Selling & Marketing Expenses 00000063.8500087.47000125.05000182.38000367.01000373.37000378.27000
SG&A 1,647.61,565.21,818.351,232.441,310.271,041.341,253.391,102.731,081.74786.09721.1615.91629.56883.72707.49596.92599.99570.97815.95524.29505.11471.491,018.68474.52468.95490.81870.04428.19372.71356.5759.04314.55348.96314.05
Other Expenses 3,686.516.4151.4841.9734.819.8910.0422.3751.7427.38-169.9451.7869.8758.65-60.430.7220.8413.39-12884.6651.728.26-182.25102.8861.5335.24-183.6157.8464.5268.67-197.7755.3891.7151.54
Operating Expenses 3,686.51,565.21,818.352,648.192,668.732,527.832,400.712,217.542,267.842,011.991,536.551,617.921,620.741,627.791,259.851,519.881,472.341,367.951,314.911,548.521,366.211,329.931,214.271,251.541,275.91,306.191,142.981,008.971,167.69909.36869.05959.741,064.05833.15
Operating Income 1,840.31,740.5945.311,339.91,425.311,288.51847.681,095.411,280.021,057.62827.881,048.421,248.631,120.11842.41966.251,142.04936.32682.9640.83981.14930.03533.37839.32924.07812.76626.64744.05924.89668.13417.96663.92691.85681.82
Operating Income Ratio 0.2490.2420.1720.2770.2850.280.2140.2620.2810.270.2750.320.3530.3260.3070.3170.3510.3250.280.2450.350.3420.2530.3380.3550.3240.2950.3560.3710.3610.2630.360.3480.374
Total Other Income Expenses Net -549.2-587.3-178.84-181.18-162.95-163.67-88.67-30.02-70.7-44.9125.541.3759.2150.864.8726.7116.3210.05-67.9480.7746.5619.2149.0351.8-0.96-35.81-4.530.2164.3568.52-8.0255.1383.8551.21
Income Before Tax 1,291.11,153.2766.471,158.721,262.361,124.84759.011,065.391,209.321,012.71853.381,089.791,307.841,170.97847.28992.961,158.36946.37614.96721.61,027.7949.24582.4891.12923.11776.95622.14774.26989.24736.65409.94719.05775.7733.03
Income Before Tax Ratio 0.1750.160.1390.240.2520.2450.1910.2550.2660.2580.2830.3320.370.3410.3090.3260.3560.3290.2520.2760.3660.3490.2760.3590.3540.310.2930.3710.3970.3980.2580.390.390.402
Income Tax Expense 327.6259-29.86144.1239.24188.35144.2363.0815.5681.9653.6682.14123.91104.38164.8191.4681.1656.1952.2486.91100.59108.6943.5689.1468.0561.3661.3625.0557.8228.28-8.2438.2983.22105.46
Net Income 915.9831.8709.621,027.361,234.3948.6654.181,018.591,203.04945.77802.961,007.651,183.931,066.59682.47901.51,077.2890.18562.72634.69927.11840.45540.87801.38853.2712.51557.87746.13928.68708.37425.13681.04690.22624.39
Net Income Ratio 0.1240.1160.1290.2120.2470.2060.1650.2440.2640.2410.2670.3070.3350.310.2490.2960.3310.3090.2310.2420.3310.3090.2560.3230.3270.2840.2630.3570.3730.3820.2670.3690.3470.342
EPS 6.736.115.227.559.076.984.817.498.856.965.917.418.717.865.036.657.936.564.144.626.746.113.985.836.25.184.065.436.715.153.134.955.024.56
EPS Diluted 6.726.15.217.549.066.984.797.498.846.955.917.418.717.855.036.637.936.554.144.616.736.113.985.836.25.174.065.436.715.153.134.955.024.56
EBITDA 2,690.62,499.91,484.321,797.061,846.251,707.341,198.981,394.381,566.21,319.431,049.591,2691,468.091,323.81967.31,103.011,268.491,054.04761.68852.471,150.151,073.4738.81,038.091,068.4920.75790.33868.741,042.1783.04478.71780.87830.49787.46
EBITDA Ratio 0.3640.3470.2690.3720.3690.3710.3020.3340.3440.3370.3490.3870.4150.3850.3530.3620.390.3660.3120.3260.410.3950.350.4180.410.3670.3720.4160.4180.4230.3010.4230.4180.432